Literature DB >> 17107737

Intraocular implants for extended drug delivery: therapeutic applications.

J L Bourges1, C Bloquel, A Thomas, F Froussart, A Bochot, F Azan, R Gurny, D BenEzra, F Behar-Cohen.   

Abstract

An overview of ocular implants with therapeutic application potentials is provided. Various types of implants can be used as slow release devices delivering locally the needed drug for an extended period of time. Thus, multiple periocular or intraocular injections of the drug can be circumvented and secondary complications minimized. The various compositions of polymers fulfilling specific delivery goals are described. Several of these implants are undergoing clinical trials while a few are already commercialized. Despite the paramount progress in design, safety and efficacy, the place of these implants in our clinical therapeutic arsenal remains limited. Miniaturization of the implants allowing for their direct injection without the need for a complicated surgery is a necessary development avenue. Particulate systems which can be engineered to target specifically certain cells or tissues are another promising alternative. For ocular diseases affecting the choroid and outer retina, transscleral or intrasscleral implants are gaining momentum.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17107737     DOI: 10.1016/j.addr.2006.07.026

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  38 in total

1.  Drug delivery systems in children.

Authors:  Stephen Lowis
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

Review 2.  New techniques for drug delivery to the posterior eye segment.

Authors:  Esther Eljarrat-Binstock; Jacob Pe'er; Abraham J Domb
Journal:  Pharm Res       Date:  2010-02-13       Impact factor: 4.200

Review 3.  Advances in ocular drug delivery systems.

Authors:  Jennifer J Kang-Mieler; Kayla M Rudeen; Wenqiang Liu; William F Mieler
Journal:  Eye (Lond)       Date:  2020-02-18       Impact factor: 3.775

Review 4.  Nanocarriers of nanotechnology in retinal diseases.

Authors:  Ali M Al-Halafi
Journal:  Saudi J Ophthalmol       Date:  2014-03-05

Review 5.  Twin-screw extrusion of sustained-release oral dosage forms and medical implants.

Authors:  Xin Feng; Feng Zhang
Journal:  Drug Deliv Transl Res       Date:  2018-12       Impact factor: 4.617

Review 6.  Intraocular sustained-release delivery systems for triamcinolone acetonide.

Authors:  Saffar Mansoor; Baruch D Kuppermann; M Cristina Kenney
Journal:  Pharm Res       Date:  2009-01-28       Impact factor: 4.200

7.  Hydrosilylated porous silicon particles function as an intravitreal drug delivery system for daunorubicin.

Authors:  Kathrin I Hartmann; Alejandra Nieto; Elizabeth C Wu; William R Freeman; Jae Suk Kim; Jay Chhablani; Michael J Sailor; Lingyun Cheng
Journal:  J Ocul Pharmacol Ther       Date:  2013-02-28       Impact factor: 2.671

Review 8.  Ocular delivery of macromolecules.

Authors:  Yoo Chun Kim; Bryce Chiang; Xianggen Wu; Mark R Prausnitz
Journal:  J Control Release       Date:  2014-07-03       Impact factor: 9.776

9.  Subconjunctivally implantable hydrogels with degradable and thermoresponsive properties for sustained release of insulin to the retina.

Authors:  Gauri P Misra; Ravi S J Singh; Tomas S Aleman; Samuel G Jacobson; Thomas W Gardner; Tao L Lowe
Journal:  Biomaterials       Date:  2009-08-25       Impact factor: 12.479

10.  Drug delivery to posterior intraocular tissues: third Annual ARVO/Pfizer Ophthalmics Research Institute Conference.

Authors:  Henry F Edelhauser; Jeffrey H Boatright; John M Nickerson
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08-15       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.